US 8729039
Use of inhibitory oligonucleotides to treat autoimmune disease
granted A61KA61K2039/55561A61K2039/57
Quick answer
US patent 8729039 (Use of inhibitory oligonucleotides to treat autoimmune disease) held by The Regents of the University of California expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/55561, A61K2039/57, A61K38/00, A61K39/39